3.078
Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten
Protara Beats Q2 Loss Estimates - The Motley Fool
Using data filters to optimize entry into Protara Therapeutics Inc.Free High Return Stock Focus With Safety - Newser
Protara Therapeutics Q2 2025 Financial Results and Business Update - TradingView
Protara Therapeutics' Q2 net loss widens - MarketScreener
Protara Therapeutics, Inc. SEC 10-Q Report - TradingView
Protara (TARA) Announces Q2 2025 Results; Press Release Furnished | TARA SEC FilingForm 8-K - Stock Titan
Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Protara Therapeutics Reveals Strong $146M Cash Position, Multiple Clinical Milestones Coming in Next 6 Months - Stock Titan
Using RSI to spot recovery in Protara Therapeutics Inc.Equity Portfolio Outlook and Performance Summary - Newser
Backtesting results for Protara Therapeutics Inc. trading strategiesFast Return Equity Forecast With Logic - Newser
News impact scoring models applied to Protara Therapeutics Inc.Free Top Gaining Picks With Entry Signals - Newser
Applying big data sentiment scoring on Protara Therapeutics Inc.Technical Trade Plan with Entry Checklist - Newser
Tick level data insight on Protara Therapeutics Inc. volatilityFree Weekly Hot Picks With Buy Confidence - Newser
Understanding Protara Therapeutics Inc.’s price movementMomentum Detection with Entry Optimization - Newser
Published on: 2025-08-10 02:01:28 - Newser
How Protara Therapeutics Inc. stock performs during market volatilityFree Pattern Alert With ROI Driven Strategy - Newser
Does Protara Therapeutics Inc. fit your quant trading modelFree Entry Alert With Low Drawdown Strategy - Newser
Protara Therapeutics Inc. stock volume spike explainedPattern Breakout Tracker with Screener Tools - Newser
Combining price and volume data for Protara Therapeutics Inc.Neural Network Based Equity Prediction System - Newser
What earnings revisions data tells us about Protara Therapeutics Inc.Free Trade Setups With AI Powered Filters - Newser
How to build a custom watchlist for Protara Therapeutics Inc.Short-Term AI-Based Stock Price Forecast - Newser
Why Protara Therapeutics Inc. stock attracts strong analyst attentionSmart Entry Signals for Active Traders - Newser
Protara’s Losses Grew But Wall Street’s Still On Board - Finimize
What analysts say about Protara Therapeutics Inc. stockCapitalize on momentum stocks before they peak - Jammu Links News
When is Protara Therapeutics Inc. stock expected to show significant growthTransform your portfolio with high-yield stocks - Jammu Links News
How does Protara Therapeutics Inc. compare to its industry peersOutstanding trading profits - Jammu Links News
Should I hold or sell Protara Therapeutics Inc. stock in 2025Capitalize on market momentum for big wins - Jammu Links News
What catalysts could drive Protara Therapeutics Inc. stock higher in 2025Free Consultation - Jammu Links News
What are Protara Therapeutics Inc. company’s key revenue driversMaximize portfolio growth with expert advice - Jammu Links News
What are analysts’ price targets for Protara Therapeutics Inc. in the next 12 monthsPhenomenal returns - Jammu Links News
What is Protara Therapeutics Inc. company’s growth strategyGet real-time alerts on top stocks - Jammu Links News
What institutional investors are buying Protara Therapeutics Inc. stockDouble or triple returns - Jammu Links News
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Protara Therapeutics Grants $45K Worth of Stock Options and RSUs to Strategic New Employees - Stock Titan
Key External Factors That Drive Protara Therapeutics Inc. Stock Price MovementsRisk Managed Watchlist with Breakout Picks - Newser
Intrinsic Value of Protara Therapeutics Inc. Stock: Is It Undervalued or OvervaluedDaily Market Momentum Summary and Strategy - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):